- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04206904
Prevalence of Frailty in Patients With a Cardiovascular Disease and Correlations With Markers of Exercise
In the first part of this study the prevalence of frailty in patients with cardiovascular disease will be examined. Frailty is defined as a progressive age-related decline in physiological systems that results in decreased reserves of intrinsic capacity, which confers extreme vulnerability to stressors. Patients (≥65 years, men and women) suffering from heart failure or undergoing a coronary artery bypass grafing (CABG) or percutaneous coronary intervention (PCI) will be included. Based on the phenotype of Fried, frailty will be examined in the physical domain. Moreover, the nutritional, social, psychological and cognitive domain of frailty will be examined. This will result in a total score of 0 (no frailty) to 24 (severe frailty), divided into four categories: no frailty (score 0-6), minor frailty (score 7-12), moderate frailty (score 13-18) or severe frailty (score 18-24).
Besides this frailty protocol, a few other measurements will be completed to collect additional information about the functioning of the patient.
At discharge from the hospital, some of these patients will start with a cardiac rehabilitation program. To define the exercise intensity of this program, patients will perform a maximal exercise test (CPET). In the second part of this study, correlations will be examined between markers of frailty and markers of exercise from the CPET (e.g. maximal heart rate, maximal oxygen uptake).
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Limburg
-
Hasselt, Limburg, Belgium, 3500
- Jessa Hospital Campus Virga Jesse
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Men and women with an age of at least 65 years at the start of the study; Staying in Jessa Hospital for PCI, CABG or heart failure
Exclusion Criteria:
A persistently unstable clinical condition at baseline visit (angina, advanced conduction disturbances, threatening ventricular arrhythmias, acute heart failure, clinical condition requiring interventions such as acute renal failure, Hb <9,0 mg/dl, presence of end-stage disease or the lack of informed consent to study participation)
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of (in)dependence via the Katz scale
Time Frame: At baseline
|
Evaluation of the level of (in)dependence in activities of daily life via a 4-point scale (1-4)
|
At baseline
|
Nutritional status via the Mini Nutritional Assessment (MNA)
Time Frame: At baseline
|
Examination of the nutritional status of the patient via a questionnaire (30 points)
|
At baseline
|
Level of physical activity via the International Physical Activity Questionnaire (IPAQ)
Time Frame: At baseline
|
Examination of the level of physical activity of the patient via a questionnaire
|
At baseline
|
Cognitive status via the Mini Mental State Examination (MMSE)
Time Frame: At baseline
|
Examination of the cognitive status of the patient via a short screening (30 points)
|
At baseline
|
Psychological status via the Geriatric Depression Scale (GDS-15)
Time Frame: At baseline
|
Examination of the presence/absence of a depressive mood via a questionnaire (15 questions/15 points)
|
At baseline
|
Concern about falling via the Falls Efficacy Scale (FES-I)
Time Frame: At baseline
|
Examination of the level of concern about falling during social and physical activities via a questionnaire (16 questions/ 64 points)
|
At baseline
|
Weight loss via the evaluation of body weight
Time Frame: At baseline
|
Evaluation of involuntary loss of body weight in the previous months
|
At baseline
|
Gait speed via the 4.6 meter walking test
Time Frame: At baseline
|
Examination of the walking speed of the patient
|
At baseline
|
Evaluation of handgrip strength
Time Frame: At baseline
|
Evaluation of the handgrip strength of the patient via handheld dynamometry
|
At baseline
|
Examination of mobility/balance/muscle strength/risk of falling via the Timed Up and Go Test (TUG)
Time Frame: At baseline
|
The Timed Up and Go Test measures the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
By combining this test with a motor or cognitive dual task, the risk of falling of the patient will be examined.
|
At baseline
|
Comorbidities via the record of medication use
Time Frame: At baseline
|
Record of cardiac and other medications
|
At baseline
|
Evaluation of lower limb strength
Time Frame: At baseline
|
Evaluation of lower limb strength of the patient via Microfet measurements
|
At baseline
|
Evaluation of functional lower limb strength
Time Frame: At baseline
|
Evaluation of functional lower limb strength of the patient via the Timed Chair Stand Test
|
At baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlations between frailty (via the primary frailty outcome measures) and exercise parameters (via the maximal exercise test (CPET)
Time Frame: At the start of the cardiac rehabilitation program
|
Evaluation of correlations between frailty characteristics (from the primary outcome measures) and exercise parameters from a maximal exercise test (CPET) (performed at the start of a cardiac rehabilitation program).
|
At the start of the cardiac rehabilitation program
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FrCR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
The Hong Kong Polytechnic UniversityCompleted
-
Xijing HospitalUnknownFrailty SyndromeChina
-
Region ZealandUniversity of Southern DenmarkActive, not recruitingFrailty SyndromeDenmark
-
Neurological Associates of West Los AngelesEnrolling by invitation
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted
-
University of Erlangen-Nürnberg Medical SchoolCompleted